Webp untitled%2520design%2520(16)
FDA Commissioner Robert Califf, M.D

The pharmaceutical industry acted like a drug cartel.

Cartels

The pharmaceutical industry's role in the opioid crisis has been likened to that of a drug cartel, according to a recent exposé by NPR. The article sheds light on the intricate connections between the pharmaceutical industry, legislation, law enforcement, Mexican drug cartels, and the devastating opioid crisis that has plagued the nation. It underscores the urgent need for accountability and addressing the root causes of this epidemic.

NPR reveals that the pharmaceutical industry has wielded significant influence over legislation, including the 2016 Ensuring Patient Access and Effective Law Enforcement Act. This particular law limited the Drug Enforcement Administration's (DEA) ability to pursue drug distributors, thereby enabling the widespread proliferation of highly addictive opioids.

The article also highlights the challenges faced by the DEA in combating the opioid epidemic. Changes in laws and the industry's powerful influence have hindered their enforcement efforts, making it increasingly difficult to hold those responsible accountable.

Furthermore, the rise of fentanyl in the opioid market has been facilitated by Mexican drug cartels. Fentanyl's potency and ease of manufacture have made it an attractive option for these cartels, resulting in a surge of overdose deaths across the country.

Perhaps most concerning is the lack of accountability and justice within the pharmaceutical industry. Despite fines and settlements, company practices remain largely unchanged, and no executives of Fortune 500 companies involved in the opioid trade have been charged with crimes. This stark reality underscores the urgent need for systemic changes that hold the industry accountable for its actions.

The NPR article sheds light on the pharmaceutical industry's role in the opioid crisis, drawing parallels to a drug cartel. It emphasizes the need for accountability and addressing the root causes of this devastating epidemic. The article challenges our society to confront the powerful influence of pharmaceutical companies, legislation, and Mexican drug cartels, in order to bring about meaningful change and prevent further loss of life.

More News